Amendment of Table A of Schedule 1 to the principal Order2

1

Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order) shall be amended in accordance with the following provisions of this article.

2

In Table A (internal or external use)—

a

delete the entry “Noscapine” in column 1 and the entry “15mg (MD) 60mg (MDD)” in relation to it in column 4; and

b

delete the entry “Noscapine Hydrochloride” in column 1 and the entry “Equivalent to 15mg of Noscapine (MD) Equivalent to 60mg of Noscapine (MDD)” in relation to it in column 4.